INTRODUCTION
Ducchene muscular dystrophy (DMD) is the most common form of all muscular dystrophies and it is an X-linked disorder. Patients experience difficulty in ambulation which steadily progresses to wheel chair confinement by the age of 12 and death between 25-30 years of age due to respiratory muscle weakness or cardiomyopathy. Lack of dystrophin, a structural sarcolemma protein that stabilizes the muscle fibre, causes muscle fibre degeneration, inflammation and fibrosis, clinically manifested as muscle weakness.
[ 
CASE REPORT
A patient named Navadeep age 9 yrs. from Andrapradesh came to our JSS hospital with H/o of
A B S T R A C T
Ducchen's muscular dystrophy is most common X-linked recessive disorder affecting 30 in 100,000 live male births. The primary cause of this disease is mutations in Dystrophin gene which is essential for the structural and functional integrity of muscle. It is a progressive muscle wasting disease in which patients frequently develop contractures and lose the ability to walk between 6 and 12 years of age. With progressive disease most patients succumb to death from respiratory failure and cardiac dysfunction in their twenties. As this is a genetic disorder we can consider it as Adibala Pravritta Vyadhi. As Mamsa Kshaya is seen at some muscles and Mamsa Vriddhi at other this is an Avarana Vata Vyadhi. In both Upsthambha and Nirupasthmbha Vatavyadhi, Basthi is considered as prime choice of treatment. A Variety of Ksheerabasti in the form of Kalabasti is studied in this condition by taking subjective and objective parameters. As this has given better improvement with no adverse effects in the patient, it can be tried in large number of patients.
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Karmaksahya of both upper and lower limbs since 3 years, Gamaneashaktata since 3 years associated with Ruja in all 4 limbs. According to the statement of his mother, he was born as a full term baby by LSCS (cord around the neck). The Anti natal, perinatal and post natal period was uneventful. All the developmental milestones were normalup to the age of 6years, according to the history given by mother.
Later the boy started complaining of pain and weakness of both lower limbs and gradually he started walking on toes, difficulty in walking with frequent falls. Difficulty in getting up from the floor and climbing stairs. Then they approached NIMS Hyderabad and AIIMS New Delhi, there he was diagnosed as DMD, but there was no improvement in the condition with treatment. After few months patient attenders noticed weakness in both upper limbs also.
O/E -Vitals normal CNS examination: Higher mental functionsNormal
Cranial nerve examination -Normal
Motor system
1. Tropical changes: darkening and roughness of skin fold on the knees and ankle joints. 
Brief about DMD
DMD is also called pseudo hypertrophic muscular dystrophy,has an incidence of 30 per 100000 live born males.
[2]
Clinical features
The boy falls frequently and have difficulty keeping up with friends when playing.By age 5 yrs muscle weakness is obvious by muscle testing, On getting up from the floor,the patient uses his hands to climb up himself (Gower'smanoeuvre). Contractures of the heel cords and iliotibial bands become apparent by age 6 years, when toe walking is associated with a lordotic posture. By age 16-18 years, patients are predisposed to serious, sometimes fatal pulmonary infections other causes of death include aspiration of food and acute gastric dilation.
Investigations
Serum CPK invariably elevated to between 20-100 times normal.
EMG demonstrates features typical of myopathy.
Muscle biopsy shows muscle fibres of varying size as well as small groups of necrotic and regenerating fibres.
A definitive diagnosis of DMD can be established on the basis of dystrophin deficiency in a biopsy of muscle tissue or mutation analysis on peripheral blood. The most common gene mutation is adeletion.
[3]
Treatment
Glucocorticoids, administered as prednisone in a dose of 0.75 mg/kg, significantly slow progression of DMD for up to 3 yrs.
Ayurvedic Approach
Two sittings of treatment was given in the interval of 2 months.
Ksheera Basti a form of Niruhabasti was alternate with Anuvasana Basti was given in the Kalabasti pattern for 16 days inthe morning time.
Niruha Basti

Makshika -50ml
Saindhava -2gms
Mahasneha -50ml
Satapuspha kalka -10 gms
Ashwaganda, Bala, Shatavari Ksheera Kashaya 200ml
Anuvasana Basti
Mahasneha -50ml
Sarvanga Shastika Shali Pinda Sweda with Mahamasataila Abhyanga for 20 days in the evening time.
OBSERVATION
Patient was well tolerated to this Niruha Basti dosage there was no complications occurred during Basti Karma. The retention time for Niruha Basti is 10-15 minutes, and for Anuvasanabasti it is 3-4 hours.
RESULTS
Serum CPK is the indicator for assessing the reduced muscle destruction and prognosis in DMD the changes in serum CPK level before and after the treatment summarised as follows . Shastikashali Pinda Sweda with Maha Masa Taila Abhyanga was advised. Mahamasha Taila specially indicated when there is Stabdata and Sankocha. [8] Shastikashali having the properties of Sheeta Virya, Snigda, Laghu, Madhura, Tridoshashamaka. of Vata. DMD is due to genetic defect there is no hope for restoring dystrophin production but this research work shows reduced serum CPK level 7080 IU in the first sitting, 1560 IU in the 2 nd sitting of treatment this could be a sign of decreased muscle damage.
CONCLUSION
Ksheera Basti in the form of Kala Basti with Shastikashali Pinda Sweda, treatment has given significant improvements in subjective and objective parameter in the patient of Duchene's muscular dystrophy. Its effect can be further studied in large number of patients.
